Literature DB >> 21683840

Continued controversy regarding adverse events after Amplatzer septal device closure: mass hysteria or tip of the iceberg?

Daniel J DiBardino1, John E Mayer.   

Abstract

Mesh：

Year:  2011        PMID： 21683840     DOI： 10.1016/j.jtcvs.2011.04.014

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  4 in total

Review 1.  State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.

Authors:  Michael L O'Byrne; Daniel S Levi
Journal:  Interv Cardiol Clin       Date:  2019-01

2.  Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database.

Authors:  Michael L O'Byrne; Russell T Shinohara; Elena K Grant; Joshua P Kanter; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2017-07-19       Impact factor: 4.749

Review 3.  Transcatheter device closure of atrial septal defects: more to think about than just closing the hole.

Authors:  Michael L O'Byrne; Andrew C Glatz; Matthew J Gillespie
Journal:  Curr Opin Cardiol       Date:  2018-01       Impact factor: 2.161

4.  Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects.

Authors:  Michael L O'Byrne; Andrew C Glatz; Sherzana Sunderji; Aswathi E Mathew; David J Goldberg; Yoav Dori; Jonathan J Rome; Matthew J Gillespie
Journal:  Pediatr Cardiol       Date:  2014-05-14       Impact factor: 1.655
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.